S Samuelsson

Summary

Affiliation: Statens Serum Institut
Country: Denmark

Publications

  1. doi Risk of adverse birth outcome after group B meningococcal disease: results from a Danish national cohort
    Michael F Howitz
    Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    Pediatr Infect Dis J 28:199-203. 2009
  2. doi National case-control study on risk of death and Neisseria meningitidis sequence types in Denmark, 2000-2007
    Michael Howitz
    Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    APMIS 116:1107-15. 2008
  3. doi Surveillance of bacterial meningitis in children under 2 y of age in Denmark, 1997-2006
    Michael Howitz
    Department of Epidemiology, Statens Serum Institute, Copenhagen, Denmark
    Scand J Infect Dis 40:881-7. 2008
  4. ncbi Lack of association between group B meningococcal disease and autoimmune disease
    Michael Howitz
    Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    Clin Infect Dis 45:1327-34. 2007
  5. pmc Declining incidence of meningococcal disease in Denmark, confirmed by a capture-recapture analysis for 1994 and 2002
    M F Howitz
    Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    Epidemiol Infect 136:1088-95. 2008
  6. ncbi Campylobacter, polyneuropathy, and Guillain-Barré syndrome in Denmark, 1994-2003
    Michael Frantz Howitz
    Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    Scand J Infect Dis 39:160-2. 2007
  7. ncbi Hepatitis A outbreak in a group of Danish tourists returning from Turkey, October 2005
    Michael Howitz
    Department of Epidemiology, Statens Serum Institut, Denmark
    Euro Surveill 10:E051201.2. 2005
  8. ncbi Using sentinel surveillance to monitor effectiveness of influenza vaccine is feasible: a pilot study in Denmark
    A Mazick
    European Programme for Intervention Epidemiology Training EPIET, Department of Epidemiology, Statens Serum Institut, Denmark
    Euro Surveill 11:254-6. 2006
  9. ncbi Ascertainment of meningococcal disease in Europe
    C Trotter
    Health Protection Agency Centre for Infections, London, United Kingdom
    Euro Surveill 10:247-50. 2005
  10. pmc Effectiveness of different policies in preventing meningococcal disease clusters following a single case in day-care and pre-school settings in Europe
    D Boccia
    European Programme for Intervention Epidemiology Training, Health Protection Agency Centre for Infections, London, UK
    Epidemiol Infect 134:872-7. 2006

Collaborators

Detail Information

Publications11

  1. doi Risk of adverse birth outcome after group B meningococcal disease: results from a Danish national cohort
    Michael F Howitz
    Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    Pediatr Infect Dis J 28:199-203. 2009
    ....
  2. doi National case-control study on risk of death and Neisseria meningitidis sequence types in Denmark, 2000-2007
    Michael Howitz
    Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    APMIS 116:1107-15. 2008
    ..If this notion can be confirmed by other studies, it may stimulate additional research regarding the pathogenesis of severe illness, for example, if certain surface molecules trigger a cytokine storm more than others...
  3. doi Surveillance of bacterial meningitis in children under 2 y of age in Denmark, 1997-2006
    Michael Howitz
    Department of Epidemiology, Statens Serum Institute, Copenhagen, Denmark
    Scand J Infect Dis 40:881-7. 2008
    ....
  4. ncbi Lack of association between group B meningococcal disease and autoimmune disease
    Michael Howitz
    Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    Clin Infect Dis 45:1327-34. 2007
    ..Because systemic infection with GBM induces serum antibody in adults, we investigated whether persons with a history of GBM disease are at increased risk of developing autoimmune diseases...
  5. pmc Declining incidence of meningococcal disease in Denmark, confirmed by a capture-recapture analysis for 1994 and 2002
    M F Howitz
    Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    Epidemiol Infect 136:1088-95. 2008
    ..The complete registration which includes a unique personal identification number serves as an outstanding source for nationwide registry linkage studies...
  6. ncbi Campylobacter, polyneuropathy, and Guillain-Barré syndrome in Denmark, 1994-2003
    Michael Frantz Howitz
    Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    Scand J Infect Dis 39:160-2. 2007
    ..The increase in Campylobacter cases in Denmark in the 1990s was comparable to an increase in cases of unspecified polyneuropathies; however, the incidence of Guillain-Barré syndrome cases remained stable during the period...
  7. ncbi Hepatitis A outbreak in a group of Danish tourists returning from Turkey, October 2005
    Michael Howitz
    Department of Epidemiology, Statens Serum Institut, Denmark
    Euro Surveill 10:E051201.2. 2005
  8. ncbi Using sentinel surveillance to monitor effectiveness of influenza vaccine is feasible: a pilot study in Denmark
    A Mazick
    European Programme for Intervention Epidemiology Training EPIET, Department of Epidemiology, Statens Serum Institut, Denmark
    Euro Surveill 11:254-6. 2006
    ..Expansion to a European multicountry study could overcome this limitation and provide VE estimates earlier in the season, for different age groups and emerging virus strains, including new and pandemic subtypes...
  9. ncbi Ascertainment of meningococcal disease in Europe
    C Trotter
    Health Protection Agency Centre for Infections, London, United Kingdom
    Euro Surveill 10:247-50. 2005
    ..These findings are relevant to the surveillance of other infectious diseases, particularly those with lower mortality and a lower public profile than meningococcal disease, for which ascertainment may be worse...
  10. pmc Effectiveness of different policies in preventing meningococcal disease clusters following a single case in day-care and pre-school settings in Europe
    D Boccia
    European Programme for Intervention Epidemiology Training, Health Protection Agency Centre for Infections, London, UK
    Epidemiol Infect 134:872-7. 2006
    ..8, 95% CI 0.7-22.0), although the difference was not statistically significant (P=0.22). The costs of this approach and the low risk of clustering need to be taken into account when deciding national policy...
  11. ncbi Meningococcal disease--still a major challenge
    S Samuelsson
    Commun Dis Public Health 5:178-80. 2002